These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 1363409)

  • 1. Acute effects of hydrocortisone on circulating growth hormone levels in patients with acromegaly.
    Giustina A; Bussi AR; Licini M; Pizzocolo G; Schettino M; Wehrenberg WB
    Horm Res; 1992; 37(6):212-6. PubMed ID: 1363409
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of hydrocortisone on the growth hormone response to growth hormone-releasing hormone in acromegaly.
    Giustina A; Bussi AR; Doga M; Wehrenberg WB
    Horm Res; 1994; 41(1):33-7. PubMed ID: 8013941
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of glucocorticoids on the paradoxical growth hormone response to thyrotropin-releasing hormone in patients with acromegaly.
    Giustina A; Doga M; Bresciani E; Bussi AR; Chiesa L; Misitano V; Giustina G
    Metabolism; 1995 Mar; 44(3):379-83. PubMed ID: 7885285
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Arginine blocks the inhibitory effect of hydrocortisone on circulating growth hormone levels in patients with acromegaly.
    Giustina A; Schettino M; Bossoni S; Bussi AR; Doga M; Licini M; Wehrenberg WB
    Metabolism; 1993 May; 42(5):664-8. PubMed ID: 8492725
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hexarelin, a novel GHRP-6 analog, counteracts the inhibitory effect of hydrocortisone on growth hormone secretion in acromegaly.
    Giustina A; Bresciani E; Bugari G; Bussi AR; Deghenghi R; Imbimbo B; Giustina G
    Endocr Res; 1995 Aug; 21(3):569-82. PubMed ID: 7588427
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of pyridostigmine on the hydrocortisone-mediated decrease of circulating growth hormone levels in acromegaly.
    Giustina A; Bussi AR; Doga M; Iacobello C; Wehrenberg WB
    Horm Metab Res; 1994 Jun; 26(6):288-92. PubMed ID: 7927192
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of metoclopramide on the paradoxical growth hormone response to galanin in acromegaly.
    Giustina A; Doga M; Bodini C; Bossoni S; Bresciani E; Bussi AR
    Endocr Res; 1993 Dec; 19(4):303-15. PubMed ID: 7508379
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Galanin decreases circulating growth hormone levels in acromegaly.
    Giustina A; Bodini C; Doga M; Schettino M; Pizzocolo G; Giustina G
    J Clin Endocrinol Metab; 1992 Jun; 74(6):1296-300. PubMed ID: 1375598
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reciprocal relationship between the level of circulating cortisol and growth hormone secretion in response to growth hormone-releasing hormone in man: studies in patients with adrenal insufficiency.
    Giustina A; Bresciani E; Bossoni S; Chiesa L; Misitano V; Wehrenberg WB; Veldhuis JD
    J Clin Endocrinol Metab; 1994 Nov; 79(5):1266-72. PubMed ID: 7962318
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of long-term treatment with bromocriptine on the growth hormone response to galanin in patients with acromegaly.
    Giustina A; Doga M; Bussi AR; Licini M; Schettino M
    Acta Endocrinol (Copenh); 1993 Feb; 128(2):131-5. PubMed ID: 7680832
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Studies on the response of growth hormone (GH) secretion to GH-releasing hormone, thyrotropin-releasing hormone, gonadotropin-releasing hormone, and somatostatin in acromegaly.
    Shibasaki T; Hotta M; Masuda A; Imaki T; Obara N; Hizuka N; Takano K; Wakabayashi I; Demura H; Ling N
    J Clin Endocrinol Metab; 1986 Jul; 63(1):167-73. PubMed ID: 2872226
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Growth hormone and prolactin responses to bolus and sustained infusions of GRH-1-40-OH in man.
    Goldman JA; Molitch ME; Thorner MO; Vale W; Rivier J; Reichlin S
    J Endocrinol Invest; 1987 Aug; 10(4):397-406. PubMed ID: 3119697
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of the paradoxical growth hormone inhibitory effect of galanin in acromegaly.
    Giustina A; Bresciani E; Bussi AR; Bollati A; Bonfanti C; Bugari G; Chiesa L; Giustina G
    J Clin Endocrinol Metab; 1995 Apr; 80(4):1333-40. PubMed ID: 7536207
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pulsatile growth hormone secretion in patients with acromegaly and normal men: the effects of growth hormone-releasing hormone infusion.
    Gelato MC; Oldfield E; Loriaux DL; Merriam GR
    J Clin Endocrinol Metab; 1990 Sep; 71(3):585-90. PubMed ID: 2118536
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Growth hormone-releasing hormone infusion in patients with active acromegaly.
    Losa M; Chiodini PG; Liuzzi A; König A; Müller OA; Schopohl J; von Werder K
    J Clin Endocrinol Metab; 1986 Jul; 63(1):88-93. PubMed ID: 3086362
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modulation of postinhibitory rebound rise in plasma GH by hypothalamic hormones in patients with acromegaly.
    Hanew K; Sasaki A; Sato S; Goh M; Shimizu Y; Murakami O; Yoshinaga K
    Endocrinol Jpn; 1984 Dec; 31(6):793-800. PubMed ID: 6152422
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The mechanism of postinhibitory rebound increases in plasma gh in acromegalic patients.
    Hanew K; Sasaki A; Sato S; Kasai M; Shimizu Y; Murakami O; Yoshinaga K
    Tohoku J Exp Med; 1984 Jan; 142(1):59-65. PubMed ID: 6144195
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Failure of growth hormone-suppressing agents to affect TSH-releasing hormone- and LH-releasing hormone-induced growth hormone release in acromegaly.
    Nakagawa K; Obara T
    J Clin Endocrinol Metab; 1977 Jan; 44(1):189-93. PubMed ID: 401823
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased growth hormone pulse frequency in acromegaly.
    Barkan AL; Stred SE; Reno K; Markovs M; Hopwood NJ; Kelch RP; Beitins IZ
    J Clin Endocrinol Metab; 1989 Dec; 69(6):1225-33. PubMed ID: 2511221
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human pancreatic growth hormone-releasing factor (hpGRF-44) in acromegaly before and after adenomectomy. Modifications induced by somatostatin (GHRIH) infusion.
    Arosio M; Ambrosi B; Guglielmino L; Faglia G
    J Endocrinol Invest; 1985 Oct; 8(5):449-53. PubMed ID: 2867112
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.